Latest News about NVO
Recent news which mentions NVO
10 Health Care Stocks Whale Activity In Today's Session
December 11, 2024
From Benzinga
From Benzinga
Warning: This Skyrocketing Stock Has a Hidden Risk
December 10, 2024
From Motley Fool
Eli Lilly Stock Just Got Even Sweeter. Here's Why It's Worth Buying Now
December 09, 2024
From Motley Fool
Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt
December 07, 2024
From Benzinga
3 No-Brainer Growth Stocks to Buy in December
December 07, 2024
From Motley Fool
Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's What It Says.
December 07, 2024
From Motley Fool
How Much Did Americans Overspend On Weight Loss Medications in 2024? GoodRx Reveals
December 05, 2024
From Benzinga
This Healthcare Stock Is a Favorite of Billionaires. But Is It a Buy?
December 05, 2024
From Motley Fool
Wegovy Maker Novo Nordisk To Buy Novavax's Czech Republic Manufacturing Facility For $200 Million
December 04, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 04, 2024
From Benzinga
Stock Of The Day: Where Will The Eli Lilly Rally End?
December 04, 2024
From Benzinga
From Benzinga
Eli Lilly Just Got a Bundle of Good News: Time to Buy?
December 04, 2024
From Motley Fool
From Benzinga
Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk Momentum
December 03, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 02, 2024
From Benzinga
Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump
December 02, 2024
From Benzinga
From Benzinga
From Motley Fool
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
November 29, 2024
From Benzinga
The Ultimate Pharmaceutical Stock to Buy With $1,000 Right Now
November 27, 2024
From Motley Fool
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
November 26, 2024
From Benzinga
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
November 25, 2024
From Motley Fool
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
November 21, 2024
From Benzinga
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
November 20, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.